144 related articles for article (PubMed ID: 37314952)
1. Clinical Pharmacogenomic MT-RNR1 Screening for Aminoglycoside-Induced Ototoxicity and the Post-Test Counseling Conundrum.
Rigobello R; Shaw J; Ilg D; Zimmerman R; Edelmann L; Kornreich R; Scott SA; Cody N
Clin Pharmacol Ther; 2023 Aug; 114(2):262-265. PubMed ID: 37314952
[TBL] [Abstract][Full Text] [Related]
2. Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT-RNR1 Genotype.
McDermott JH; Wolf J; Hoshitsuki K; Huddart R; Caudle KE; Whirl-Carrillo M; Steyger PS; Smith RJH; Cody N; Rodriguez-Antona C; Klein TE; Newman WG
Clin Pharmacol Ther; 2022 Feb; 111(2):366-372. PubMed ID: 34032273
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacogenetics of aminoglycoside ototoxicity: State of knowledge and practices - Recommendations of the Francophone Network of Pharmacogenetics (RNPGx)].
Lebreton L; Hennart B; Baklouti S; Trimouille A; Boyer JC; Becquemont L; Dhaenens CM; Picard N
Therapie; 2024 Jun; ():. PubMed ID: 38876950
[TBL] [Abstract][Full Text] [Related]
4. Rapid Point-of-Care Genotyping to Avoid Aminoglycoside-Induced Ototoxicity in Neonatal Intensive Care.
McDermott JH; Mahaveer A; James RA; Booth N; Turner M; Harvey KE; Miele G; Beaman GM; Stoddard DC; Tricker K; Corry RJ; Garlick J; Ainsworth S; Beevers T; Bruce IA; Body R; Ulph F; MacLeod R; Roberts PL; Wilson PM; Newman WG;
JAMA Pediatr; 2022 May; 176(5):486-492. PubMed ID: 35311942
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of aminoglycoside-related ototoxicity: a systematic review.
Gaafar D; Baxter N; Cranswick N; Christodoulou J; Gwee A
J Antimicrob Chemother; 2024 Jul; 79(7):1508-1528. PubMed ID: 38629462
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of mitochondrial mutations associated with aminoglycoside-induced deafness in ethnic Latvian population: the appraisal of the evidence.
Igumnova V; Veidemane L; Vīksna A; Capligina V; Zole E; Ranka R
J Hum Genet; 2019 Mar; 64(3):199-206. PubMed ID: 30523288
[TBL] [Abstract][Full Text] [Related]
7. Normal hearing in a child with the m.1555A>G mutation despite repeated exposure to aminoglycosides. Has the penetrance of this pharmacogenetic interaction been overestimated?
Al-Malky G; Suri R; Sirimanna T; Dawson SJ
Int J Pediatr Otorhinolaryngol; 2014 Jun; 78(6):969-73. PubMed ID: 24703164
[TBL] [Abstract][Full Text] [Related]
8. Aminoglycoside induced ototoxicity risk in the cystic fibrosis population: The utility of large-scale screening.
Lopes J; Vidal-Folch N; Lundquist P; Schimmenti LA; Demirel N; Dean V; Olson J; Auth T; Butz M; Reed K; Wylam M; Balcom J; Boczek NJ; Hasadsri L
Pediatr Pulmonol; 2023 Mar; 58(3):819-824. PubMed ID: 36437230
[TBL] [Abstract][Full Text] [Related]
9. [Aminoglycoside ototoxicity associated with mitochondrial DNA mutation].
Ke X; Qi Y; Gu Z; Zhang Z; Zhang W; Jiang S; Liu J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 May; 13(5):195-7. PubMed ID: 12563999
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial haplotypes may modulate the phenotypic manifestation of the deafness-associated 12S rRNA 1555A>G mutation.
Lu J; Qian Y; Li Z; Yang A; Zhu Y; Li R; Yang L; Tang X; Chen B; Ding Y; Li Y; You J; Zheng J; Tao Z; Zhao F; Wang J; Sun D; Zhao J; Meng Y; Guan MX
Mitochondrion; 2010 Jan; 10(1):69-81. PubMed ID: 19818876
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical features of the mitochondrial m.1555A>G mutation in Taiwanese patients with idiopathic sensorineural hearing loss and association of haplogroup F with low penetrance in three families.
Wu CC; Chiu YH; Chen PJ; Hsu CJ
Ear Hear; 2007 Jun; 28(3):332-42. PubMed ID: 17485982
[TBL] [Abstract][Full Text] [Related]
12. Maternally transmitted aminoglycoside-induced and non-syndromic hearing loss caused by the 1494C > T mutation in the mitochondrial 12S rRNA gene in two Chinese families.
Wei Q; Xu D; Chen Z; Li H; Lu Y; Liu C; Bu X; Xing G; Cao X
Int J Audiol; 2013 Feb; 52(2):98-103. PubMed ID: 23237192
[TBL] [Abstract][Full Text] [Related]
13. Detecting mitochondrial mutations associated with aminoglycoside ototoxicity by noninvasive prenatal testing.
Huang Q; Liu Y; Lei W; Liang J; Wang Y; Zheng M; Huang X; Liu Y; Huang K; Huang M
J Clin Lab Anal; 2023 Jan; 37(1):e24827. PubMed ID: 36579624
[TBL] [Abstract][Full Text] [Related]
14. Genetic susceptibility to aminoglycoside ototoxicity.
Nguyen T; Jeyakumar A
Int J Pediatr Otorhinolaryngol; 2019 May; 120():15-19. PubMed ID: 30743189
[TBL] [Abstract][Full Text] [Related]
15. Frequency and spectrum of mitochondrial 12S rRNA variants in 440 Han Chinese hearing impaired pediatric subjects from two otology clinics.
Shen Z; Zheng J; Chen B; Peng G; Zhang T; Gong S; Zhu Y; Zhang C; Li R; Yang L; Zhou J; Cai T; Jin L; Lu J; Guan MX
J Transl Med; 2011 Jan; 9():4. PubMed ID: 21205314
[TBL] [Abstract][Full Text] [Related]
16. Genetics of aminoglycoside-induced and prelingual non-syndromic mitochondrial hearing impairment: a review.
Bindu LH; Reddy PP
Int J Audiol; 2008 Nov; 47(11):702-7. PubMed ID: 19031229
[TBL] [Abstract][Full Text] [Related]
17. Rapid identification of an A1555G mutation in human mitochondrial DNA implicated in aminoglycoside-induced ototoxicity.
Scrimshaw BJ; Faed JM; Tate WP; Yun K
J Hum Genet; 1999; 44(6):388-90. PubMed ID: 10570910
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial mutation m.1555A>G as a risk factor for failed newborn hearing screening in a large cohort of preterm infants.
Göpel W; Berkowski S; Preuss M; Ziegler A; Küster H; Felderhoff-Müser U; Gortner L; Mögel M; Härtel C; Herting E;
BMC Pediatr; 2014 Aug; 14():210. PubMed ID: 25155176
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
